Search

Your search keyword '"Blaise, Didier"' showing total 2,344 results
Start Over Author "Blaise, Didier" Search Limiters Available in Library Collection
2,344 results on '"Blaise, Didier"'

1. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years

Author

Berning, Philipp, Fekom, Mathilde, Ngoya, Maud, Goldstone, Anthony H., Dreger, Peter, Montoto, Silvia, Finel, Hervé, Shumilov, Evgenii, Chevallier, Patrice, Blaise, Didier, Strüssmann, Tim, Carpenter, Ben, Forcade, Edouard, Castilla-Llorente, Cristina, Trneny, Marek, Ghesquieres, Hervé, Capria, Saveria, Thieblemont, Catherine, Blau, Igor Wolfgang, Meijer, Ellen, Broers, Annoek E. C., Huynh, Anne, Caillot, Denis, Rösler, Wolf, Nguyen Quoc, Stephanie, Bittenbring, Jörg, Nagler, Arnon, Galimard, Jacques-Emmanuel, Glass, Bertram, Sureda, Anna, and Schmitz, Norbert

Published
2024
Full Text
View/download PDF

2. Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

Author

Ye, Yishan, Labopin, Myriam, Chen, Jia, Wu, Depei, Gedde-Dahl, Sr., Tobias, Blaise, Didier, Socie, Gérard, Forcade, Edouard, Salmenniemi, Urpu, Maury, Sébastien, Versluis, Jurjen, Bazarbachi, Ali, Nagler, Arnon, Brissot, Eolia, Li, Lin, Luo, Yi, Shi, Jimin, Ciceri, Fabio, Huang, He, Mohty, Mohamad, and Gorin, Norbert Claude

Published
2024
Full Text
View/download PDF

3. Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

Author

Brissot, Eolia, Labopin, Myriam, Labussière, Helene, Fossard, Gaelle, Chevallier, Patrice, Guillaume, Thierry, Yakoub-Agha, Ibrahim, Srour, Micha, Bulabois, Claude-Eric, Huynh, Anne, Chantepie, Sylvain, Menard, Anne-Lise, Rubio, Marie-Therese, Ceballos, Patrice, Dulery, Rémy, Furst, Sabine, Malard, Florent, Blaise, Didier, and Mohty, Mohamad

Published
2024
Full Text
View/download PDF

4. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

Author

Montoro, Juan, Ngoya, Maud, Kulagin, Alexander, Giebel, Sebastian, Broers, Annoek E. C., Bramanti, Stefania, Halahleh, Khalid, Pérez-Simón, Jose A., Solano, Carlos, Ozcelik, Tulay, Blaise, Didier, Sanz, Jaime, Henriques, Marta, Peffault de Latour, Régis, Martino, Rodrigo, Scheid, Christof, Fox, Laura, Gromek, Tomasz, Jurado, Manuel, Sakellari, Ioanna, Van Gorkom, Gwendolyn, Matteucci, Paola, Nagler, Arnon, Koc, Yener, and Glass, Bertram

Published
2024
Full Text
View/download PDF

6. Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT

Author

Sanz, Jaime, Labopin, Myriam, Blaise, Didier, Raiola, Anna Maria, Busca, Alessandro, Vydra, Jan, Tischer, Johanna, Chevallier, Patrice, Bramanti, Stefania, Fanin, Renato, Socié, Gérard, Forcade, Edouard, Kröger, Nicolaus, Koc, Yener, Itäla-Remes, Maija, Zecca, Marco, Nagler, Arnon, Brissot, Eolia, Spyridonidis, Alexandros, Bazarbachi, Ali, Giebel, Sebastian, Piemontese, Simona, Mohty, Mohamad, and Ciceri, Fabio

Published
2024
Full Text
View/download PDF

7. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

Author

Nagler, Arnon, Labopin, Myriam, Blaise, Didier, Raiola, Anna Maria, Corral, Lucia Lopez, Bramanti, Stefania, Sica, Simona, Kwon, Mi, Koc, Yener, Pavlu, Jiri, Kulagin, Alexander, Busca, Alessandro, Rodríguez, Arancha Bermúdez, Reményi, Péter, Schmid, Christoph, Brissot, Eolia, Sanz, Jaime, Bazarbachi, Ali, Giebel, Sebastian, Ciceri, Fabio, and Mohty, Mohamad

Published
2023
Full Text
View/download PDF

8. Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

Author

Nagler, Arnon, Labopin, Myriam, Blaise, Didier, Raiola, Anna Maria, Corral, Lucia Lopez, Bramanti, Stefania, Sica, Simona, Kwon, Mi, Koc, Yener, Pavlu, Jiri, Kulagin, Alexander, Busca, Alessandro, Rodríguez, Arancha Bermúdez, Reményi, Péter, Schmid, Christoph, Brissot, Eolia, Sanz, Jaime, Bazarbachi, Ali, Giebel, Sebastian, Ciceri, Fabio, and Mohty, Mohamad

Published
2023
Full Text
View/download PDF

9. Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Ye, Yishan, Labopin, Myriam, Chen, Jia, Gulbas, Zafer, Zhang, Xi, Koc, Yener, Blaise, Didier, Ciceri, Fabio, Polge, Emmanuelle, Houhou, Mohamed, Li, Lin, Luo, Yi, Wu, Depei, Huang, He, Mohty, Mohamad, and Gorin, Norbert-Claude

Published
2023
Full Text
View/download PDF

11. Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

Author

Ai, Huisheng, Chao, Nelson J., Rizzieri, David A., Huang, Xiaojun, Spitzer, Thomas R., Wang, Jianxiang, Guo, Mei, Keating, Armand, Krakow, Elizabeth F., Blaise, Didier, Ma, Jun, Wu, Depei, Reagan, John, Gergis, Usama, Duarte, Rafael F., Chaudhary, Preet M., Hu, Kaixun, Yu, Changlin, Sun, Qiyun, Fuchs, Ephraim, Cai, Bo, Huang, Yajing, Qiao, Jianhui, Gottlieb, David, Schultz, Kirk R., Liu, Mingyao, Chen, Xiequn, Chen, Wenming, Wang, Jianmin, Zhang, Xiaohui, Li, Jianyong, Huang, He, Sun, Zimin, Li, Fei, Yang, Linhua, Zhang, Liansheng, Li, Lijuan, Liu, Kaiyan, Jin, Jie, Liu, Qifa, Liu, Daihong, Gao, Chunji, Fan, Chuanbo, Wei, Li, Zhang, Xi, Hu, Liangding, Zhang, Weijing, Tian, Yuyang, Han, Weidong, Zhu, Jun, Xiao, Zhijian, Zhou, Daobin, Zhang, Bolong, Jia, Yongqian, Zhang, Yongqing, Wu, Xiaoxiong, Shen, Xuliang, Lu, Xuzhang, Zhan, Xinrong, Sun, Xiuli, Xiao, Yi, Wang, Jingbo, Shi, Xiaodong, Zheng, Bo, Chen, Jieping, Ding, Banghe, Wang, Zhao, Zhou, Fan, Zhang, Mei, Zhang, Yizhuo, Sun, Jie, Xia, Bing, Chen, Baoan, and Ma, Liangming

Published
2023
Full Text
View/download PDF

12. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Author

Dholaria, Bhagirathbhai, Savani, Bipin N, Labopin, Myriam, Luznik, Leo, Ruggeri, Annalisa, Mielke, Stephan, Malki, Monzr M Al, Kongtim, Piyanuch, Fuchs, Ephraim, Huang, Xiao-Jun, Locatelli, Franco, Aversa, Franco, Castagna, Luca, Bacigalupo, Andrea, Martelli, Massimo, Blaise, Didier, Soussan, Patrick Ben, Arnault, Yolande, Handgretinger, Rupert, Roy, Denis-Claude, O’Donnell, Paul, Bashey, Asad, Solomon, Scott, Romee, Rizwan, Lewalle, Philippe, Gayoso, Jorge, Maschan, Michael, Lazarus, Hillard M, Ballen, Karen, Giebel, Sebastian, Baron, Frederic, Ciceri, Fabio, Esteve, Jordi, Gorin, Norbert-Claude, Spyridonidis, Alexandros, Schmid, Christoph, Ciurea, Stefan O, Nagler, Arnon, and Mohty, Mohamad

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Immunology, Transplantation, Cancer, Regenerative Medicine, Rare Diseases, Prevention, Hematology, Stem Cell Research, Inflammatory and immune system, Consensus, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Lymphocytes, Prospective Studies, Retrospective Studies, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology
Abstract

Donor lymphocyte infusion has been used in the management of relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. It can eradicate minimal residual disease or be used to rescue a hematologic relapse, being able to induce durable remissions in a subset of patients. With the increased use of haploidentical hematopoietic cell transplantation, there is renewed interest in the use of donor lymphocytes to either treat or prevent disease relapse post transplant. Published retrospective and small prospective studies have shown encouraging results with therapeutic donor lymphocyte infusion in different haploidentical transplantation platforms. In this consensus paper, finalized on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, we summarize the available evidence on the use of donor lymphocyte infusion from haploidentical donor, and provide recommendations on its therapeutic, pre-emptive and prophylactic use in clinical practice.

Published
2020

14. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.

Author

Dreger, Peter, Sureda, Anna, Ahn, Kwang, Eapen, Mary, Litovich, Carlos, Finel, Herve, Boumendil, Ariane, Gopal, Ajay, Herrera, Alex, Schmid, Christoph, Diez-Martin, José, Fuchs, Ephraim, Bolaños-Meade, Javier, Gooptu, Mahasweta, Al Malki, Monzr, Castagna, Luca, Ciurea, Stefan, Dominietto, Alida, Blaise, Didier, Ciceri, Fabio, Tischer, Johanna, Corradini, Paolo, Montoto, Silvia, Robinson, Stephen, Gülbas, Zafer, and Hamadani, Mehdi

Subjects
Adult, Aged, Female, Hematopoietic Stem Cell Transplantation, Humans, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Retrospective Studies, Tissue Donors, Transplantation Conditioning, Young Adult
Abstract

This study retrospectively compared long-term outcomes of nonmyeloablative/reduced intensity conditioning (NMC/RIC) allogeneic hematopoietic cell transplantation (allo-HCT) from a haploidentical family donor (haplo-HCT) using posttransplant cyclophosphamide (PTCy) with those of matched sibling donor (MSD) and matched unrelated donor (MUD) with or without T-cell depletion (TCD+/TCD-) in patients with relapsed diffuse large B-cell lymphoma (DLBCL). Adult patients with DLBCL who had undergone their first NMC/RIC allo-HCT between 2008 and 2015 were included. Recipients of haplo-HCT were limited to those receiving graft-versus-host disease (GVHD) prophylaxis with PTCy. GVHD prophylaxis in MSD was limited to calcineurin inhibitor (CNI)-based approaches without in vivo TCD, while MUD recipients received CNI-based prophylaxis with or without TCD. Outcome analyses for overall survival (OS) and progression-free survival (PFS), nonrelapse mortality (NRM), and disease relapse/progression were calculated. A total of 1438 patients (haplo, 132; MSD, 525; MUD TCD+, 403; and MUD TCD-, 378) were included. Patients with haplo donors were significantly older, had a better performance status and had more frequently received total body irradiation-based conditioning regimens and bone marrow grafts than MSD and MUD TCD+ or TCD-. 3-year OS, PFS, NRM and relapse/progression incidence after haplo-HCT was 46%, 38%, 22%, and 41%, respectively, and not significantly different from outcomes of matched donor transplants on multivariate analyses. Haplo-HCT was associated with a lower cumulative incidence of chronic GVHD compared with MSD, MUD TCD+/TCD-. NMC/RIC haplo-HCT with PTCy seems to be a valuable alternative for patients with DLBCL considered for allo-HCT but lacking a matched donor.

Published
2019

15. Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

Author

Sahebi, Firoozeh, Garderet, Laurent, Kanate, Abraham S, Eikema, Diderik-Jan, Knelange, Nina Simone, Alvelo, Omar F Dávila, Koc, Yener, Blaise, Didier, Bashir, Qaiser, Moraleda, José M, Dreger, Peter, Sanchez, James F, Ciurea, Stefan, Schouten, Harry, Shah, Nirav N, Verbeek, Mareike, Rösler, Wolf, Diez-Martin, Jose L, Schoenland, Stefan, D'Souza, Anita, Kröger, Nicolaus, and Hari, Parameswaran

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Regenerative Medicine, Stem Cell Research, Clinical Trials and Supportive Activities, Transplantation, Clinical Research, Hematology, Rare Diseases, Cancer, Good Health and Well Being, Adult, Aged, Allografts, Disease-Free Survival, Female, Follow-Up Studies, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Incidence, Male, Middle Aged, Multiple Myeloma, Recurrence, Retrospective Studies, Risk Factors, Survival Rate, Allogeneic hematopoietic cell transplantation, Haploidentical, Multiple myeloma, Clinical Sciences, Immunology, Cardiovascular medicine and haematology
Abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) using siblings and matched donors has the potential for long-term disease control in a subset of high-risk patients with multiple myeloma (MM); however, the data on using haploidentical donors in this disease are limited. We conducted a retrospective analysis to examine the outcomes of patients with MM who underwent haploidentical allo-HCT within European Society for Blood and Marrow Transplantation/Center for International Blood and Marrow Transplant Research centers. A total of 96 patients underwent haploidentical allo-HCT between 2008 and 2016. With a median follow-up of 24.0 months (range, 13.2 to 24.9 months), 97% (95% confidence interval [CI], 93% to 100%) of patients had neutrophil engraftment by day 28, and 75% (95% CI, 66% to 84%) achieved platelet recovery by day 60. Two-year progression-free survival (PFS) was 17% (95% CI, 8% to 26%), and overall survival (OS) was 48% (95% CI, 36% to 59%). At 2 years, the cumulative risk of relapse/progression was 56% (95% CI, 45% to 67%), and 1-year nonrelapse mortality (NRM) was 21% (95% CI, 13% to 29%). The incidences of acute graft-versus-host-disease (GVHD) grades II-IV by 100 days and chronic GVHD at 2 years were 39% (95% CI, 28% to 49%) and 46% (95% CI, 34% to 59%), respectively. On univariate analysis, use of post-transplantation cyclophosphamide (PT-Cy) (54% [95% CI, 41% to 68%] versus 25% [95% CI, 1% to 48%]; P =.009) and use of bone marrow as source of stem cells (72% [95% CI, 55% to 89%] versus 31% [95% CI, 17% to 46%]; P = .001) were associated with improved OS at 2 years. Disease status, patient sex, intensity of conditioning regimen, recipient/donor sex mismatch, and cytomegalovirus serostatus had no impact on OS, PFS, or NRM. Haploidentical transplantation is feasible for patients with multiply relapsed or high-risk MM, with an encouraging 2-year OS of 48% and an NRM of 21% at 1 year, supporting further investigation of haploidentical allo-HCT in suitable candidates with MM.

Published
2019

16. High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

Author

Chretien, Anne-Sophie, Devillier, Raynier, Granjeaud, Samuel, Cordier, Charlotte, Demerle, Clemence, Salem, Nassim, Wlosik, Julia, Orlanducci, Florence, Gorvel, Laurent, Fattori, Stephane, Hospital, Marie-Anne, Pakradouni, Jihane, Gregori, Emilie, Paul, Magali, Rochigneux, Philippe, Pagliardini, Thomas, Morey, Mathieu, Fauriat, Cyril, Dulphy, Nicolas, Toubert, Antoine, Luche, Herve, Malissen, Marie, Blaise, Didier, Nunès, Jacques A., Vey, Norbert, and Olive, Daniel

Published
2021

17. In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study

Author

Devillier, Raynier, Forcade, Edouard, Garnier, Alice, Guenounou, Sarah, Thepot, Sylvian, Guillerm, Gaelle, Ceballos, Patrice, Hicheri, Yosr, Dumas, Pierre-Yves, Peterlin, Pierre, Hunault-Berger, Mathilde, Béné, Marie-Christine, Bouvier, Anne, Chevallier, Patrice, Blaise, Didier, Vey, Norbert, Pigneux, Arnaud, Récher, Christian, and Huynh, Anne

Published
2022
Full Text
View/download PDF

18. Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics

Author

Hamadani, Mehdi, Ngoya, Maud, Sureda, Anna, Bashir, Qaiser, Litovich, Carlos Alejandro, Finel, Hervé, Chen, Yue, Boumendil, Ariane, Zain, Jasmine, Castagna, Luca, Cashen, Amanda F., Blaise, Didier, Shadman, Mazyar, Pastano, Rocco, Khimani, Farhad, Arat, Mutlu, Dietrich, Sascha, Schmitz, Norbert, Glass, Bertram, Kharfan-Dabaja, Mohamed A., Corradini, Paolo, Sauter, Craig S., Montoto, Silvia, Kwon, Mi, Herrera, Alex F., and Dreger, Peter

Published
2022
Full Text
View/download PDF

19. Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Devillier, Raynier, Galimard, Jacques‐Emmanuel, Blaise, Didier, Raiola, Anna Maria, Bramanti, Stefania, Grillo, Giovanni, Pastano, Rocco, de Latour, Régis Peffault, Busca, Alessandro, López‐Corral, Lucía, Rodríguez, Arancha Bermúdez, Schmid, Christoph, Forcade, Edouard, Vydra, Jan, Solano, Carlos, Bug, Gesine, Neubauer, Andreas, Charbonnier, Amandine, Brissot, Eolia, and Nagler, Arnon

Published
2024
Full Text
View/download PDF

20. The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience

Author

Blaise, Didier, Berger, Pierre, Mokart, Djamel, Camerlo, Jacques, Fougereau, Emmanuelle, Giovannini, Marc, Houvenaeghel, Gilles, Turrini, Olivier, Chabannon, Christian, Piana, Gilles, Brenot-Rossi, Isabelle, Tallet, Agnès, Gonçalves, Anthony, Charbonnier, Aude, Vey, Norbert, Grossi, Sabrina, and Viens, Patrice

Published
2021
Full Text
View/download PDF

21. Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Author

Robinson, Tara, Fuchs, Ephraim, Zhang, Mei-Jie, St Martin, Andrew, Labopin, Myriam, Keesler, Daniel, Blaise, Didier, Bashey, Asad, Bourhis, Jean-Henri, Ciceri, Fabio, Ciurea, Stefan, Devine, Steven, Mohty, Mohamad, McCurdy, Shannon, Milpied, Noel, McNiece, Ian, Rocha, Vanderson, Romee, Rizwan, Socie, Gerard, Yakoub-Agha, Ibrahim, Soiffer, Robert, Eapen, Mary, and Nagler, Arnon

Subjects
Acute Disease, Adolescent, Adult, Aged, Chronic Disease, Cyclophosphamide, Disease-Free Survival, Female, Graft vs Host Disease, HLA Antigens, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Male, Middle Aged, Survival Rate, Tissue Donors
Abstract

We sought to identify whether posttransplantation cyclophosphamide (PT-Cy) reduces or eliminates the detrimental impact of HLA mismatching on outcomes of HLA-haploidentical related donor transplantation for acute leukemia. Data from 2143 donor-recipient pairs (n = 218 haploidentical sibling; n = 218 offspring; n = 1707 HLA-matched sibling) with acute myeloid or lymphoblastic leukemia were studied. All received a calcineurin inhibitor for graft-versus-host disease (GVHD) prophylaxis while high-dose PT-Cy was also given to recipients of haploidentical transplant. Patient age correlated with donor-recipient relationship: haploidentical siblings donated to patients aged 18 to 54 years whereas offspring donated to patients aged 55 to 76 years. Therefore, transplant outcomes were examined separately in the 2 patient age groups. In patients aged 18 to 54 years, there were no significant differences in outcomes except chronic GVHD, which was lower after haploidentical sibling compared to HLA-matched sibling transplant (hazard ratio [HR], 0.63; P < .001). In patients aged 55 to 76 years, despite lower chronic GVHD (HR, 0.42; P < .001), graft failure (14% vs 6%; P = .003), nonrelapse mortality (HR, 1.48; P = .02), and overall mortality (HR, 1.32; P = .003) were higher after transplant from offspring compared with an HLA-matched sibling. These data demonstrate a superior outcome in older recipients when using an HLA-matched sibling instead of offspring, although there were differences in transplant platforms (GVHD prophylaxis and graft type) between the 2 groups. Validation of these findings requires a prospective randomized trial wherein the transplant platforms can be closely matched.

Published
2018

22. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

Author

Ciurea, Stefan O, Cao, Kai, Fernandez-Vina, Marcelo, Kongtim, Piyanuch, Malki, Monzr Al, Fuchs, Ephraim, Luznik, Leo, Huang, Xiao-Jun, Ciceri, Fabio, Locatelli, Franco, Aversa, Franco, Castagna, Luca, Bacigalupo, Andrea, Martelli, Massimo, Blaise, Didier, Handgretinger, Rupert, Roy, Denis-Claude, O’Donnell, Paul, Bashey, Asad, Lazarus, Hillard M, Ballen, Karen, Savani, Bipin N, Mohty, Mohamad, and Nagler, Arnon

Subjects
Transplantation, Regenerative Medicine, Stem Cell Research, Organ Transplantation, Development of treatments and therapeutic interventions, 5.4 Surgery, Inflammatory and immune system, Bone Marrow Transplantation, Graft Rejection, HLA Antigens, Hematopoietic Stem Cell Transplantation, Humans, Isoantibodies, Tissue Donors, Transplantation, Haploidentical, Treatment Outcome, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

Haploidentical donors are now increasingly considered for transplantation in the absence of HLA-matched donors or when an urgent transplant is needed. Donor-specific anti-HLA antibodies (DSA) have been recently recognized as an important barrier against successful engraftment of donor cells, which can affect transplant survival. DSA appear more prevalent in this type of transplant due to higher likelihood of alloimmunization of multiparous females against offspring's HLA antigens, and the degree of mismatch. Here we summarize the evidence for the role of DSA in the development of primary graft failure in haploidentical transplantation and provide consensus recommendations from the European Society for Blood and Marrow Transplant Group on testing, monitoring, and treatment of patients with DSA receiving haploidentical hematopoietic progenitor cell transplantation.

Published
2018

23. Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT

Author

Raj, Kavita, Eikema, Dirk-Jan, Sheth, Vipul, Koster, Linda, de Wreede, Liesbeth C., Blaise, Didier, Di Grazia, Carmela, Koc, Yener, Potter, Victoria, Chevallier, Patrice, Lopez- Corral, Lucia, Wu, Depei, Mielke, Stephan, Maertens, Johan, Meijer, Ellen, Huynh, Anne, Passweg, Jakob, Luft, Thomas, Pérez-Simón, Jose Antonio, Ciceri, Fabio, Piekarska, Agnieszka, Hayri Ozsan, G., Kröger, Nicolaus, Robin, Marie, and Yakoub-Agha, Ibrahim

Published
2022
Full Text
View/download PDF

24. Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT

Author

Polverelli, Nicola, primary, Bonneville, Edouard F., additional, de Wreede, Liesbeth C., additional, Koster, Linda, additional, Kröger, Nicolaus Martin, additional, Schroeder, Thomas, additional, Peffault de Latour, Régis, additional, Passweg, Jakob, additional, Sockel, Katja, additional, Broers, Annoek E. C., additional, Clark, Andrew, additional, Dreger, Peter, additional, Blaise, Didier, additional, Yakoub‐Agha, Ibrahim, additional, Petersen, Soeren Lykke, additional, Finke, Jürgen, additional, Chevallier, Patrice, additional, Helbig, Grzegorz, additional, Rabitsch, Werner, additional, Sammassimo, Simona, additional, Arcaini, Luca, additional, Russo, Domenico, additional, Drozd‐Sokolowska, Joanna, additional, Raj, Kavita, additional, Robin, Marie, additional, Battipaglia, Giorgia, additional, Czerw, Tomasz, additional, Hernández‐Boluda, Juan Carlos, additional, and McLornan, Donal P., additional

Published
2024
Full Text
View/download PDF

25. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Author

Moukalled, Nour, primary, Labopin, Myriam, additional, Versluis, Jurjen, additional, Socié, Gérard, additional, Blaise, Didier, additional, Salmenniemi, Urpu, additional, Rambaldi, Alessandro, additional, Gedde‐Dahl, Tobias, additional, Tholouli, Eleni, additional, Kröger, Nicolaus, additional, Bourhis, Jean‐Henri, additional, Von Dem Borne, Peter, additional, Daguindau, Etienne, additional, Forcade, Edouard, additional, Nagler, Arnon, additional, Esteve, Jordi, additional, Ciceri, Fabio, additional, Bazarbachi, Ali, additional, and Mohty, Mohamad, additional

Published
2024
Full Text
View/download PDF

26. Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas

Author

Montes de Oca, Catalina, Castagna, Luca, De Philippis, Chiara, Bramanti, Stefania, Schiano, Jean Marc, Pagliardini, Thomas, Collignon, Aude, Harbi, Samia, Mariotti, Jacopo, Granata, Angela, Maisano, Valerio, Furst, Sabine, Legrand, Faezeah, Chabannon, Christian, Carlo-Stella, Carmelo, Santoro, Armando, Blaise, Didier, and Devillier, Raynier

Published
2020
Full Text
View/download PDF

27. Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers—On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT

Author

Sheth, Vipul, Volt, Fernanda, Sanz, Jaime, Clement, Laurence, Cornelissen, Jan, Blaise, Didier, Sierra, Jorge, Michallet, Mauricette, Saccardi, Riccardo, Rocha, Vanderson, Gluckman, Eliane, Chabannon, Christian, and Ruggeri, Annalisa

Published
2020
Full Text
View/download PDF

28. Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy

Author

Mariotti, Jacopo, Raiola, Anna Maria, Evangelista, Andrea, Carella, Angelo Michele, Martino, Massimo, Patriarca, Francesca, Risitano, Antonio, Bramanti, Stefania, Busca, Alessandro, Giaccone, Luisa, Brunello, Lucia, Merla, Emanuela, Savino, Lucia, Loteta, Barbara, Console, Giuseppe, Fanin, Renato, Sperotto, Alessandra, Marano, Luana, Marotta, Serena, Frieri, Camilla, Sica, Simona, Chiusolo, Patrizia, Harbi, Samia, Furst, Sabine, Santoro, Armando, Bacigalupo, Andrea, Blaise, Didier, Angelucci, Emanuele, Mavilio, Domenico, Castagna, Luca, and Bruno, Benedetto

Published
2020
Full Text
View/download PDF

29. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Author

Bazarbachi, Ali, Labopin, Myriam, Angelucci, Emanuele, Gülbas, Zafer, Ozdogu, Hakan, Arat, Mutlu, de Rosa, Luca, Pastano, Rocco, Pioltelli, Pietro, Montserrat, Rovira, Martino, Massimo, Ciceri, Fabio, Koç, Yener, Socié, Gerard, Blaise, Didier, Herrera, Concepcion, Chalandon, Yves, Bernasconi, Paolo, Marotta, Giuseppe, Castagna, Luca, McDonald, Andrew, Visani, Guiseppe, Carluccio, Paola, Vitek, Antonin, Simand, Célestine, Afanasyev, Boris, Rösler, Wolf, Diez-Martin, J.L., Nagler, Arnon, Brissot, Eolia, Giebel, Sebastian, and Mohty, Mohamad

Published
2020
Full Text
View/download PDF

30. Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation

Author

Heilig, Christoph E., Badoglio, Manuela, Labopin, Myriam, Fröhling, Stefan, Secondino, Simona, Heinz, Jürgen, Nicolas-Virelizier, Emmanuelle, Blaise, Didier, Korenbaum, Clément, Santoro, Armando, Verbeek, Mareike, Krüger, William, Siena, Salvatore, Passweg, Jakob R., Di Nicola, Massimo, Rifón, Jose, Dreger, Peter, Koehl, Ulrike, Chabannon, Christian, and Pedrazzoli, Paolo

Published
2020
Full Text
View/download PDF

31. Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.

Author

Al Malki, Monzr, Horowitz, Mary, Handgretinger, Rupert, Leung, Wing, Roy, Denis-Claude, Huang, Xiao-Jun, Fuchs, Ephraim, Locatelli, Franco, Blaise, Didier, Mineishi, Shin, Martelli, Massimo, Miller, Jeffrey, June, Carl, Ai, Hui-Sheng, Luznik, Leo, Mavilio, Domenico, Lugli, Enrico, van den Brink, Marcel, Champlin, Richard, and Ciurea, Stefan

Subjects
Cellular therapy, Haploidentical transplantation, Immunologic reconstitution after transplantation, Post-transplantation cyclophosphamide, T cell depleted, Animals, Antineoplastic Agents, Alkylating, Clinical Trials as Topic, Cyclophosphamide, Disease Models, Animal, Graft vs Host Disease, HLA Antigens, Hematologic Neoplasms, Histocompatibility Testing, Humans, Mice, Recurrence, San Francisco, Secondary Prevention, Stem Cell Transplantation, Survival Analysis, T-Lymphocytes, Regulatory, Transplantation, Isogeneic, Unrelated Donors
Abstract

Significant progress has been made over the past decade in haploidentical transplantation, with the development of novel methods to control intense alloreactive reactions generated in the major HLA-mismatched setting. Application of post-transplantation cyclophosphamide has gained worldwide acceptance as an effective and low-cost way to perform this type of transplantation, with outcomes now similar to those from HLA-matched unrelated donors. These advances have resulted in improved treatment-related mortality, whereas disease relapse has emerged as the most common cause of treatment failure. In addition, improvements in immunologic reconstitution after transplantation are much needed, not only in haploidentical transplantation but in all forms of stem cell transplantation. This symposium has focused on some of the most promising methods to control alloreactivity in this form of transplantation and application of cellular therapy to prevent disease relapse after transplantation, as well as understanding immunologic reconstitution and foreseeable approaches to improve immune recovery after transplantation.

Published
2016

32. Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT

Author

Rovó, Alicia, primary, Gras, Luuk, additional, Piepenbroek, Brian, additional, Kröger, Nicolaus, additional, Reinhardt, H. Christian, additional, Radujkovic, Aleksandar, additional, Blaise, Didier, additional, Kobbe, Guido, additional, Niityvuopio, Riitta, additional, Platzbecker, Uwe, additional, Sockel, Katja, additional, Hunault‐Berger, Mathilde, additional, Cornelissen, J. J., additional, Forcade, Edouard, additional, Bourhis, Jean Henri, additional, Chalandon, Yves, additional, Kinsella, Francesca, additional, Nguyen‐Quoc, Stéphanie, additional, Maertens, Johan, additional, Elmaagacli, Ahmet, additional, Mordini, Nicola, additional, Hayden, Patrick, additional, Raj, Kavita, additional, Drozd‐Sokolowska, Joanna, additional, de Wreede, Liesbeth C., additional, McLornan, Donal P., additional, Robin, Marie, additional, Yakoub‐Agha, Ibrahim, additional, and Onida, Francesco, additional

Published
2023
Full Text
View/download PDF

33. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

Author

Dholaria, Bhagirathbhai, Labopin, Myriam, Sanz, Jaime, Ruggeri, Annalisa, Cornelissen, Jan, Labussière-Wallet, Hélène, Blaise, Didier, Forcade, Edouard, Chevallier, Patrice, Grassi, Anna, Zubarovskaya, Ludmila, Kuball, Jürgen, Ceballos, Patrice, Ciceri, Fabio, Baron, Frederic, Savani, Bipin N., Nagler, Arnon, and Mohty, Mohamad

Published
2021
Full Text
View/download PDF

34. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Author

Garnache-Ottou, Francine, Vidal, Chrystelle, Biichlé, Sabeha, Renosi, Florian, Poret, Eve, Pagadoy, Maïder, Desmarets, Maxime, Roggy, Anne, Seilles, Estelle, Soret, Lou, Schillinger, Françoise, Puyraimond, Sandrine, Petrella, Tony, Preudhomme, Claude, Roumier, Christophe, MacIntyre, Elisabeth A., Harrivel, Véronique, Desbrosses, Yohan, Gruson, Bérengère, Geneviève, Franck, Thepot, Sylvain, Drebit, Yuriy, Leguay, Thibaut, Gros, François-Xavier, Lechevalier, Nicolas, Saussoy, Pascale, Salaun, Véronique, Cornet, Edouard, Benseddik, Zehaira, Veyrat-Masson, Richard, Wagner-Ballon, Orianne, Salanoubat, Célia, Maynadié, Marc, Guy, Julien, Caillot, Denis, Jacob, Marie-Christine, Cahn, Jean-Yves, Gressin, Rémy, Rose, Johann, Quesnel, Bruno, Guerin, Estelle, Trimoreau, Franck, Feuillard, Jean, Gourin, Marie-Pierre, Plesa, Adriana, Baseggio, Lucile, Arnoux, Isabelle, Vey, Norbert, Blaise, Didier, Lacroix, Romaric, Arnoulet, Christine, Benet, Blandine, Dorvaux, Véronique, Bret, Caroline, Drenou, Bernard, Debliquis, Agathe, Latger-Cannard, Véronique, Bonmati, Caroline, Bene, Marie-Christine, Peterlin, Pierre, Ticchioni, Michel, Rohrlich, Pierre-Simon, Arnaud, Anne, Wickenhauser, Stefan, Bardet, Valérie, Brechignac, Sabine, Papoular, Benjamin, Raggueneau, Victoria, Vargaftig, Jacques, Letestu, Rémi, Lusina, Daniel, Braun, Thorsten, Foissaud, Vincent, Tamburini, Jérôme, Bennani, Hind, Freynet, Nicolas, Cordonnier, Catherine, Le Garff-Tavernier, Magali, Jacques, Nathalie, Maloum, Karim, Roos-Weil, Damien, Bouscary, Didier, Asnafi, Vahid, Lhermitte, Ludovic, Suarez, Felipe, Lengline, Etienne, Féger, Frédéric, Battipaglia, Giorgia, Mohty, Mohamad, Bouyer, Sabrina, Ghoual, Ouda, Dindinaud, Elodie, Basle, Caroline, Puyade, Mathieu, Lafon, Carinne, Fest, Thierry, Roussel, Mikael, Cahu, Xavier, Bera, Elsa, Daliphard, Sylvie, Jardin, Fabrice, Campos, Lydia, Solly, Françoise, Guyotat, Denis, Galoisy, Anne-Cécile, Eischen, Alice, Mayeur-Rousse, Caroline, Guffroy, Blandine, Recher, Christian, Loosveld, Marie, Garnier, Alice, Barlogis, Vincent, Rosenthal, Maria Alessandra, Brun, Sophie, Contentin, Nathalie, Maury, Sébastien, Callanan, Mary, Lefebvre, Christine, Maillard, Natacha, Okamba, Patricia, Ferrand, Christophe, Adotevi, Olivier, Saas, Philippe, Angelot-Delettre, Fanny, Binda, Delphine, and Deconinck, Eric

Published
2019
Full Text
View/download PDF

35. Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Gagelmann, Nico, Eikema, Diderik-Jan, Koster, Linda, Caillot, Denis, Pioltelli, Pietro, Lleonart, Juan Bargay, Reményi, Péter, Blaise, Didier, Schaap, Nicolaas, Trneny, Marek, Passweg, Jakob, Porras, Rocio Parody, Cahn, Jean Yves, Musso, Maurizio, Poiré, Xavier, Fenk, Roland, Itälä-Remes, Maija, Pavone, Vincenzo, Fouillard, Loic, Maertens, Johan, Bron, Dominique, Pouli, Anastasia, Schroyens, Wilfried, Schönland, Stefan, Garderet, Laurent, Yakoub-Agha, Ibrahim, and Kröger, Nicolaus

Published
2019
Full Text
View/download PDF

36. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Shimoni, Avichai, Labopin, Myriam, Savani, Bipin, Byrne, Michael, Volin, Liisa, Finke, Jürgen, Niederwieser, Dietger, Ehninger, Gerhard, Blaise, Didier, Beelen, Dietrich, Tabrizi, Reza, Sengeloev, Henrik, Ganser, Arnold, Cornelissen, Jan J., Mohty, Mohamad, and Nagler, Arnon

Published
2019
Full Text
View/download PDF

37. Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

Author

Mussetti, Alberto, Kanate, Abraham S., Wang, Tao, He, Meilun, Hamadani, Mehdi, Finel, Hervé, Sr., Boumendil, Ariane, Sr., Glass, Bertram, Castagna, Luca, Dominietto, Alida, McGuirk, Joseph, Blaise, Didier, Gülbas, Zafer, Diez-Martin, Jose, Marsh, Steven G.E., Paczesny, Sophie, Gadalla, Shahinaz M., Dreger, Peter, Zhang, Mei-Jie, Spellman, Stephen R., Lee, Stephanie J., Bolon, Yung-Tsi, and Sureda, Anna

Published
2023
Full Text
View/download PDF

39. Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients

Author

Pagliardini, Thomas, Castagna, Lucas, Harbi, Samia, Porta, Matteo Della, Rey, Jerome, Fürst, Sabine, Bramanti, Stefania, Saillard, Colombe, Legrand, Faezeh, Maisano, Valerio, Faucher, Catherine, Granata, Angela, Hospital, Marie-Anne, Lining, Wang, Weiller, Pierre-Jean, Calmels, Boris, Charbonnier, Aude, Lemarie, Claude, Chabannon, Christian, Vey, Norbert, Mokart, Djamel, Blaise, Didier, and Devillier, Raynier

Published
2019
Full Text
View/download PDF

40. Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma

Author

Mariotti, Jacopo, Devillier, Raynier, Bramanti, Stefania, Giordano, Laura, Sarina, Barbara, Furst, Sabine, Granata, Angela, Maisano, Valerio, Pagliardini, Thomas, De Philippis, Chiara, Kogan, Maria, Faucher, Catherine, Harbi, Samia, Chabannon, Christian, Carlo-Stella, Carmelo, Bouabdallah, Reda, Santoro, Armando, Blaise, Didier, and Castagna, Luca

Published
2019
Full Text
View/download PDF

41. Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Author

Prata, Pedro H., Resche-Rigon, Matthieu, Blaise, Didier, Socié, Gérard, Rohrlich, Pierre-Simon, Milpied, Noel, Turlure, Pascal, Nguyen, Stephanie, Sirvent, Anne, Bulabois, Claude-Eric, Berceanu, Ana, Charbonnier, Amandine, Chevallier, Patrice, Bay, Jacques-Olivier, Neven, Benedicte, Jubert, Charlotte, Mohty, Mohamad, Rubio, Marie-Thérèse, and Peffault de Latour, Régis

Published
2019
Full Text
View/download PDF

42. Impact of Cytogenetic Risk on Outcomes of Non-T-Cell–Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Author

Nagler, Arnon, Labopin, Myriam, Dholaria, Bhagirathbhai, Ciceri, Fabio, Fraccaroli, Alessia, Blaise, Didier, Fanin, Renato, Bruno, Benedetto, Forcade, Edouard, Vydra, Jan, Chevallier, Patrice, Bulabois, Claude Eric, Jindra, Pavel, Bornhäuser, Martin, Canaani, Jonathan, Sanz, Jaime, Savani, Bipin N., Spyridonidis, Alexandros, Giebel, Sebastian, Brissot, Eolia, Bazarbachi, Ali, Esteve, Jordi, and Mohty, Mohamad

Published
2022
Full Text
View/download PDF

44. Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Ruggeri, Annalisa, Galimard, Jacques-Emmanuel, Labopin, Myriam, Rafii, Hanadi, Blaise, Didier, Ciceri, Fabio, Diez-Martin, Jose-Luiz, Cornelissen, Jan, Chevallier, Patrice, Sanchez-Guijo, Fermin, Nicholson, Emma, Castagna, Luca, Forcade, Edouard, Kuball, Jürgen, Rovira, Montserrat, Koc, Yener, Pavlu, Jiri, Gulbas, Zafar, Vydra, Jan, Baron, Frederic, Sanz, Jaime, Spyridonidis, Alexandros, Savani, Bipin, Gluckman, Eliane, Nagler, Arnon, and Mohty, Mohamad

Published
2022
Full Text
View/download PDF

45. Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT.

Author

Rovó, Alicia, Gras, Luuk, Piepenbroek, Brian, Kröger, Nicolaus, Reinhardt, H. Christian, Radujkovic, Aleksandar, Blaise, Didier, Kobbe, Guido, Niityvuopio, Riitta, Platzbecker, Uwe, Sockel, Katja, Hunault‐Berger, Mathilde, Cornelissen, J. J., Forcade, Edouard, Bourhis, Jean Henri, Chalandon, Yves, Kinsella, Francesca, Nguyen‐Quoc, Stéphanie, Maertens, Johan, and Elmaagacli, Ahmet

Published
2024
Full Text
View/download PDF

46. Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Battipaglia, Giorgia, Labopin, Myriam, Blaise, Didier, Diez-Martin, Jose Luis, Bazarbachi, Ali, Vitek, Antonin, Chevallier, Patrice, Castagna, Luca, Grillo, Giovanni, Daguindau, Etienne, López-Jiménez, Javier, Koc, Yener, Ruggeri, Annalisa, Nagler, Arnon, and Mohty, Mohamad

Published
2022
Full Text
View/download PDF

47. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Author

Tozatto-Maio, Karina, Giannotti, Federica, Labopin, Myriam, Ruggeri, Annalisa, Volt, Fernanda, Paviglianiti, Annalisa, Kenzey, Chantal, Hayashi, Hiromi, Cornelissen, Jan, Michallet, Mauricette, Karakasis, Dimitrios, Deconinck, Eric, Rohrlich, Pierre-Simon, de la Tour, Regis Peffault, Blaise, Didier, Petersen, Eefke, D'Aveni, Maud, Sengeloev, Henrik, Lamy, Thierry, Russell, Nigel H., Forcade, Edouard, Craddock, Charles F., Nagler, Arnon, Gluckman, Eliane, and Rocha, Vanderson

Published
2018
Full Text
View/download PDF

48. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

Author

Sengsayadeth, Salyka, Labopin, Myriam, Boumendil, Ariane, Finke, Jürgen, Ganser, Arnold, Stelljes, Matthias, Ehninger, Gerhard, Beelen, Dietrich, Niederwieser, Dietger, Blaise, Didier, Dreger, Peter, Mufti, Ghulam, Chevallier, Patrice, Mailhol, Audrey, Gatwood, Katie S., Gorin, Norbert, Esteve, Jordi, Ciceri, Fabio, Baron, Frederic, Schmid, Christoph, Giebel, Sebastian, Mohty, Mohamad, Savani, Bipin N., and Nagler, Arnon

Published
2018
Full Text
View/download PDF

49. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

Author

Garderet, Laurent, Iacobelli, Simona, Koster, Linda, Goldschmidt, Hartmut, Johansson, Jan-Erik, Bourhis, Jean Henri, Krejci, Marta, Leleu, Xavier, Potter, Michael, Blaise, Didier, Koenecke, Christian, Peschel, Christian, Radocha, Jakub, Metzner, Bernd, Lenain, Pascal, Schäfer-Eckart, Kerstin, Pohlreich, David, Grasso, Mariella, Caillot, Denis, Einsele, Herman, Ladetto, Marco, Schönland, Stefan, and Kröger, Nicolaus

Published
2018
Full Text
View/download PDF

50. HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison

Author

Devillier, Raynier, Legrand, Faezeh, Rey, Jérôme, Castagna, Luca, Fürst, Sabine, Granata, Angela, Charbonnier, Aude, Harbi, Samia, d'Incan, Evelyne, Pagliardini, Thomas, Faucher, Catherine, Lemarie, Claude, Saillard, Colombe, Calmels, Boris, Mohty, Bilal, Maisano, Valerio, Weiller, Pierre-Jean, Chabannon, Christian, Vey, Norbert, and Blaise, Didier

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results